“…With the advances of tissue engineering, novel technologies have emerged and been used as more realistic in vitro models, allowing the construction of complex cytoarchitecture, with better representation of cell heterogeneity, extracellular matrix (ECM) composition, and functionality of native tissues [ 9 ]. 3D in vitro models consist of scaffold-free (spheroids and organoids) or scaffold-based (3D scaffolding and 3D bioprinting) systems used to study infectivity, replication kinetics, and host-viral interactions of many types of viruses, such as influenza [ 10 , 11 ], syncytial [ 12 ], adenovirus [ 13 ], norovirus [ 14 ], Zika [ 15 ], and more recently, SARS-CoV-2 [ 16 ], showing increased physiological relevance as compared to 2D models.…”